Luis Rubio, MD, MHS
Assistant Professor
Medicine
School of Medicine
Dr. Luis Alberto Rubio is an infectious disease specialist who provides primary care for patients living with HIV or AIDS. His professional interests include HIV prevention and treating latent (asymptomatic) tuberculosis infections.
Show full bio (60 words) Hide full bio
In research, Rubio is interested in medical education and health care access for marginalized populations, especially those disproportionately impacted by such infections as HIV, COVID-19 and tuberculosis.
Rubio earned his medical degree and master of health science degree from the Yale School of Medicine. At UCSF, he completed a residency in internal medicine and a fellowship in infectious diseases.
Education & Training
Show all (4) Hide
- Fellowship Infectious Diseases University of California San Francisco 06/2021
- Residency Internal Medicine University of California San Francisco 06/2019
- MD, MHS Yale University School of Medicine 05/2016
- BS Biology University of Texas El Paso 05/2011
Publications (13)
Top publication keywords:
CoccidioidomycosisHospitalizationEmploymentActinomycosisBacteroides InfectionsBacteroides fragilisVaccinesAntigens, ViralInterferon Type IFearEmigration and ImmigrationResidence CharacteristicsPublic HealthPoint-of-Care TestingHelp-Seeking Behavior
-
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs.
Science immunology 2023 Bastard P, Vazquez SE, Liu J, Laurie MT, Wang CY, Gervais A, Le Voyer T, Bizien L, Zamecnik C, Philippot Q, Rosain J, Catherinot E, Willmore A, Mitchell AM, Bair R, Garçon P, Kenney H, Fekkar A, … -
Borrelia miyamotoi Infection in Immunocompromised Man, California, USA, 2021
Emerging Infectious Diseases 2023 Rubio, L. A., Kjemtrup, A. M., Marx, G. E., Cronan, S., Kilonzo, C., Saunders, M. E. M., Choat, J. L., Dietrich, E. A., Liebman, K. A., & Park, S. Y. -
SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential Cross-Neutralization of Established and Emerging Strains Including Delta and Omicron.
The Journal of infectious diseases 2022 Laurie MT, Liu J, Sunshine S, Peng J, Black D, Mitchell AM, Mann SA, Pilarowski G, Zorn KC, Rubio L, Bravo S, Marquez C, Sabatino JJ, Mittl K, Petersen M, Havlir D, DeRisi J -
Field Performance and Public Health Response Using the BinaxNOWTM Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 Pilarowski G, Marquez C, Rubio L, Peng J, Martinez J, Black D, Chamie G, Jones D, Jacobo J, Tulier-Laiwa V, Rojas S, Rojas S, Cox C, Nakamura R, Petersen M, DeRisi J, Havlir DV -
A multi-component, community-based strategy to facilitate COVID-19 vaccine uptake among Latinx populations: From theory to practice.
PloS one 2021 Marquez C, Kerkhoff AD, Naso J, Contreras MG, Castellanos Diaz E, Rojas S, Peng J, Rubio L, Jones D, Jacobo J, Rojas S, Gonzalez R, Fuchs JD, Black D, Ribeiro S, Nossokoff J, Tulier-Laiwa V, Martinez …
Show all (8 more) Hide
-
High likelihood of accepting COVID-19 vaccine in a Latinx community at high SARS-CoV2 risk in San Francisco
Open Forum Infectious Diseases 2021 Peng J, Marquez C, Rubio L, Chamie G, Jones D, Jacobo J, Rojas S, Rojas S, Tulier-Laiwa V, Black D, Martinez J, Pilarowski G, Cox C, Derisi J, Havlir H, Petersen M. -
Performance Characteristics of a Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Detection Assay at a Public Plaza Testing Site in San Francisco.
The Journal of infectious diseases 2021 Pilarowski G, Lebel P, Sunshine S, Liu J, Crawford E, Marquez C, Rubio L, Chamie G, Martinez J, Peng J, Black D, Wu W, Pak J, Laurie MT, Jones D, Miller S, Jacobo J, Rojas S, Rojas S, Nakamura R, … -
Estimation of secondary household attack rates for emergent SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco.
medRxiv : the preprint server for health sciences 2021 Peng J, Mann SA, Mitchell AM, Liu J, Laurie MT, Sunshine S, Pilarowski G, Ayscue P, Kistler A, Vanaerschot M, Li LM, McGeever A, Chow ED, Team I, Marquez C, Nakamura R, Rubio L, Chamie G, Jones D, … -
Experiences of Latinx Individuals Hospitalized for COVID-19: A Qualitative Study.
JAMA network open 2021 Cervantes L, Martin M, Frank MG, Farfan JF, Kearns M, Rubio LA, Tong A, Matus Gonzalez A, Camacho C, Collings A, Mundo W, Powe NR, Fernandez A -
The COVID-19 Symptom to Isolation Cascade in a Latinx Community: A Call to Action.
Open forum infectious diseases 2021 Rubio LA, Peng J, Rojas S, Rojas S, Crawford E, Black D, Jacobo J, Tulier-Laiwa V, Hoover CM, Martinez J, Jones D, Sachdev D, Cox C, Herrera E, Valencia R, Zurita KG, Chamie G, CLIAHUB Consortium, … -
Malignant Masses or Mysterious Mimic?
The American journal of medicine 2020 Brondfield S, Rubio L, Idossa D, Chin-Hong P -
Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.
EClinicalMedicine 2020 Shah SJ, Barish PN, Prasad PA, Kistler A, Neff N, Kamm J, Li LM, Chiu CY, Babik JM, Fang MC, Abe-Jones Y, Alipanah N, Alvarez FN, Botvinnik OB, Castaneda G, CZB CLIAhub Consortium, Dadasovich RM, … -
Coccidioidomycosis Presenting with Fever and Back Pain.
Journal of general internal medicine 2020 Pillsbury MM, Rubio LA, Lucas CG, Babik JM